Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 471.82% and ...

As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss drugs, cheaper copies of their patented ...

Since Novo's blockbuster Ozempic diabetes treatment was approved in the United States in 2017, regulators have greenlighted ...

When individual investors are asked about investment vehicles for “innovation,” the Invesco QQQ ETF and the ARKK Innovation ...

The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes ...

Charting, Price Performance, News & Related Contracts.

Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, ...

From Amazon.com's workers strike to Micron's weak earnings, here's a look at some of the major developments from across the world.

China's Shanghai Composite Index today closed -0.06% ... is down -5% after management warned of weaker Q4 earnings due to weak steel prices and weak demand in Europe. Eli Lilly (LLY) is up more than ...

No economic cycles? No mean reversion? Macquarie’s top global strategist’s radical view of markets challenges investors to ...

Eli Lilly’s Kisunla Approved in China, Paving the Way for Innovative Alzheimer’s Treatment Options Elon Musk Lights Up Tesla Buzz with $690.42 Price Target and $2 Trillion Market Cap Forecast ...